Counterpoint Mutual Funds’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,471
Closed -$260K 303
2024
Q3
$260K Buy
+2,471
New +$252K 0.05% 189
2022
Q4
Sell
-3,756
Closed -$233K 332
2022
Q3
$233K Buy
3,756
+447
+14% +$32.2K 0.57% 22
2022
Q2
$221K Buy
3,309
+2,228
+206% +$167K 0.15% 51
2022
Q1
$78K Buy
+1,081
New +$88.5K 0.06% 82
2021
Q3
Sell
-281
Closed -$14K 172
2021
Q2
$14K Buy
+281
New +$13.8K 0.01% 7

Other funds holding BXC

Counterpoint Mutual Funds's BXC Position: Q4 2024 in Review

Counterpoint Mutual Funds sold out of BlueLinx (BXC) in Q4 2024, closing a stake of 2,471 shares — an estimated $260K sold.

Counterpoint Mutual Funds first reported a position in BXC in Q2 2021 and held it in 5 quarters. The position peaked at $260K in Q3 2024. 175 funds tracked by Wall St. Rank hold BXC as of Q4 2024.

  • Counterpoint Mutual Funds reported no remaining BlueLinx position as of Q4 2024 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 2,471 BlueLinx shares in Q4 2024, an estimated $260K.
  • Counterpoint Mutual Funds first reported a position in BlueLinx in Q2 2021 and held it in 5 quarters.
  • Counterpoint Mutual Funds's BlueLinx position peaked at $260K in Q3 2024.
  • 175 funds tracked by Wall St. Rank held BlueLinx as of Q4 2024.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2024, filed 10 Feb 2025.